{"id":"W2249291309","doi":"10.1200/jco.2005.23.16_suppl.818","title":"Randomized trial of adjuvant equitoxic dose-escalated anthracycline (A)-containing regimen of doxorubicin, cyclophosphamide (AC) versus cyclophosphamide, methotrexate, 5-FU (CMF) for stage I-II breast cancer (BrCa): Can equitoxicity compensate for agent selection?","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cyclophosphamide; Anthracycline; Breast cancer; Regimen; Chemotherapy; Internal medicine; Randomized controlled trial; Radiation therapy; Oncology; Surgery; Urology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00360485,0.002208027,0.003583204,0.0005730729,0.0006579966,0.001553561,0.001673481,0.002897609,0.01013231],"category_scores_gemma":[0.00471031,0.001215517,0.001745376,0.0005274002,0.003010873,0.001589694,0.000861089,0.00551257,0.001510975],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001243978,"about_ca_system_score_gemma":0.001995543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001412766,"about_ca_topic_score_gemma":0.001852105,"domain_scores_codex":[0.997972,0.001242515,0.0001223004,0.0002727435,0.0001153039,0.0002752379],"domain_scores_gemma":[0.9960515,0.001330483,0.0008085351,0.0003920012,0.0001973081,0.001220165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9895097,0.006412618,0.0001792033,0.00009696806,0.0001682105,0.000012981,0.00002317448,0.0001761715,0.0008453592,0.00006493163,0.0001503639,0.002360321],"study_design_scores_gemma":[0.927039,0.07154667,0.0003831393,0.000009826856,0.0001352009,0.00001179746,0.00001193189,0.000308375,0.0002124356,0.0001346715,0.0001988366,0.000008188601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888428,0.0008491403,0.0006555711,0.0007019602,0.0006733389,0.006452952,0.0005052311,0.00008024542,0.001238825],"genre_scores_gemma":[0.9810911,0.0008576063,0.001918846,0.001312468,0.000729129,0.009305061,0.0006164635,0.0000230879,0.004146189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01013231,"threshold_uncertainty_score":0.03389597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1380302174512369,"score_gpt":0.4999980576242872,"score_spread":0.3619678401730503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}